1361941-11-8

Basic information

• Product Name: 2-bromo-6-(2-tert-butyl-6-oxo-4H-thieno[3,2-c]pyrrol-5(6H)-yl)benzyl acetate
• Synonyms: 2-bromo-6-(2-tert-butyl-6-oxo-4H-thieno[3,2-c]pyrrol-5(6H)-yl)benzyl acetate
• CAS NO: 1361941-11-8
• Molecular Weight: 422.343
• Mol File: 1361941-11-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-bromo-6-(2-tert-butyl-6-oxo-4H-thieno[3,2-c]pyrrol-5(6H)-yl)benzyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-6-(2-tert-butyl-6-oxo-4H-thieno[3,2-c]pyrrol-5(6H)-yl)benzyl acetate(1361941-11-8)
• EPA Substance Registry System: 2-bromo-6-(2-tert-butyl-6-oxo-4H-thieno[3,2-c]pyrrol-5(6H)-yl)benzyl acetate(1361941-11-8)

Safety Data

• Hazardous Substances Data: 1361941-11-8(Hazardous Substances Data)

Upstream product

• 1361941-09-4 3-((3-Bromo-2-(hydroxymethyl)phenylamino)methyl)-5-tert-butylthiophene-2-carboxylic acid 
• 1361941-08-3 methyl 3-((3-bromo-2-((tert-butyldimethylsilyloxy)methyl)-phenylamino)methyl)-5-tert-butylthiophene-2-carboxylate 
• 1361386-46-0 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester 
• 1361386-45-9 5-tert-butyl-3-methylthiophene-2-carboxylic acid methyl ester 
• 1147531-04-1 3-bromo-2-[[tert-butyl(dimethyl)silyl]oxymethyl] aniline 
• 861106-90-3 2-bromo-6-nitrobenzyl acetate 
• 55289-35-5 2-bromo-6-nitrotoluene 
• 58579-54-7 3-bromo-2-(bromomethyl)-1-nitrobenzene 
• 81452-54-2 methyl 3-methylthiophene-2-carboxylate 
• 61341-26-2 3-methylthenoyl chloride 
• 1361941-10-7 5-(3-bromo-2-(hydroxymethyl)phenyl)-2-tert-butyl-4H-thieno[3,2-c]pyrrol-6(5H)-one 
• 75-36-5 acetyl chloride 

Relevant articles and documents

PYRIDINONES/PYRAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF

Pyridone and pyrazinone compounds of Formula (I) including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.